Concepedia

J J Costanzi

JJ

Statistics

Publications

28

Citations

1.5K

H-Index

21

Active since

1967

Affiliations

The University of Texas Medical Branch at Galveston(Current)

SWOG Cancer Research Network

Wayne State University

University of Puget Sound

University of Arkansas for Medical Sciences

J J Costanzi is an author at The University of Texas Medical Branch at Galveston specializing in oncology, chemotherapy, and medicine.

Publications per year

1967–2009

28

Publications

28

Recombinant alfa interferon in renal cell carcinoma: a randomized trial of two routes of administration.

Hyman B. Muss, J J Costanzi, Richard D. Leavitt et al. · Journal of Clinical Oncology · 1987 · 166 citations

Pharmacy, Oncology, Pharmacotherapy +14

Combination chemotherapy and adriamycin in patients with advanced breast cancer.A Southwest Oncology Group study

Barth Hoogstraten, Stephen L. George, B. Samal et al. · Cancer · 1976 · 150 citations · Full text

Medicine, Oncology, Pharmacology +14

Phase II study of recombinant alpha-2 interferon in resistant multiple myeloma.

J J Costanzi, M. Robert Cooper, J.H. Scarffe et al. · Journal of Clinical Oncology · 1985 · 107 citations

Medicine, Immunology, Pharmacotherapy +15

Adjuvant CMFVP versus tamoxifen versus concurrent CMFVP and tamoxifen for postmenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study.

Saul E. Rivkin, S Green, Barbara Metch et al. · Journal of Clinical Oncology · 1994 · 101 citations

Medicine, Oncology, Pharmacotherapy +15

Improved survival duration with combination chemotherapy induction for multiple myeloma: a Southwest Oncology Group Study.

B G M Durie, Dennis O. Dixon, S Carter et al. · Journal of Clinical Oncology · 1986 · 89 citations

Medicine, Oncology, Pharmacology +15

1–5 of 28